Skip to main content

Table 1 List of intersection genes with differential gene expression in groups A, B, and C

From: Bioinformatic analysis of peripheral blood miRNA of breast cancer patients in relation with anthracycline cardiotoxicity

Number

Gene symbol

A vs. B FC

A vs. C FC

B vs. C FC

 

1

MAPK1

1.33

1.39

−1.46

 

2

NPHP3

1.33

1.34

1.49

 

3

ARL17A

−1.62

−1.67

1.41

 

ARL17B

−1.62

−1.67

1.41

 

LOC100294341

−1.62

−1.67

1.41

 

LOC100996709

−1.62

−1.67

1.41

 

4

MBP

1.51

1.55

1.43

 

5

RABGAP1L

−1.23

−1.28

−1.55

 

6

PHLDB2

−1.51

1.24

1.69

 

7

PECAM1

1.35

1.26

1.42

 

8

PVT1

−1.35

−1.27

− 1.23

 

9

ITGB8

1.41

−1.37

−1.41

 

10

LIPJ

1.30

1.26

1.29

 

11

ATXN2L

1.62

1.63

−1.44

 

12

TCEB3

1.48

1.45

−1.42

 

13

CTIF

1.57

1.42

1.22

 

14

OSBPL1A

1.47

1.29

−1.37

 

15

LINC01590

−1.65

1.45

1.58

 

SMIM8

−1.65

1.45

1.58

 

16

PLCB1

1.22

1.29

1.56

 

17

CENPT

1.37

−1.37

−1.35

 

18

ENGASE

1.27

1.68

1.33

 

19

FAM27B

1.36

2.22

1.64

 

FAM27C

1.36

2.22

1.64

 

LOC102725186

1.36

2.22

1.64

 

LOC105379444

1.36

2.22

1.64

 

20

SPTBN1

−1.56

−1.33

1.54

 

21

VPS53

1.29

−1.58

−1.31

 

22

RNF34

1.32

1.54

−1.36

 

23

PGM5-AS1

−1.31

2.00

1.34

 

24

FGFR1OP2

−1.47

−2.28

−2.27

 

25

GKAP1

−1.67

1.42

1.29

 

26

ZNF736

−1.79

1.27

1.36

 

27

TTC26

−1.79

1.42

1.73

 

28

TSHZ2

−1.79

−2.20

− 1.66

 

29

DUSP8

1.39

1.47

1.30

 

30

GPATCH2

−1.6

1.24

1.29

 
  1. Note: group A: female breast cancer patients with anthracycline-induced cardiotoxicity; group B (female breast cancer patients with chemotherapy history but no cardiotoxicity; group C: female breast cancer patients with normal ejection fraction before chemotherapy. Bold font indicates that the trends of the gene in group A were opposite to those in groups B and C. Red represents up-regulation of group A genes and down-regulation of groups B and C genes; green represents down-regulation of group A genes and up-regulation of groups B and C genes
  2. FC Fold Change, PHLDB2 pleckstrin homology like domain family B member 2, LINC01590 long intergenic non-protein coding RNA 1590, SMIM8 small integral membrane protein 8, CENPT centromere protein T, VPS53 VPS53 subunit of GARP complex, ITGB8:integrin subunit beta 8, TTC26 tetratricopeptide repeat domain 26, PGM5-AS1:PGM5 antisense RNA 1, GKAP1 G kinase anchoring protein 1; ZNF736:zinc finger protein 736; GPATCH2:G-patch domain containing 2;
  3. Entries in boldface font indicates that the trends of the gene in group A were opposite to those in groups B and C